We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Spanish Authority Investigates Prices of Aspen Pharma’s Cancer Drugs
Spanish Authority Investigates Prices of Aspen Pharma’s Cancer Drugs
Aspen Pharma and Deco Pharma, the company’s distributor, face disciplinary proceedings from Spain’s antitrust authority for allegedly limiting the distribution and hiking the prices of drugs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor